skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Uses of monoclonial antibody 8H9

Patent ·
OSTI ID:1185299

This invention provides an antibody that binds the same antigen as that of monoclonal antibody 8H9, wherein the heavy chain CDR (Complementary Determining Region)1 comprises NYDIN, heavy chain CDR2 comprises WIFPGDGSTQY, heavy chain CDR3 comprises QTTATWFAY, and the light chain CDR1 comprises RASQSISDYLH, light chain CDR2 comprises YASQSIS, and light chain CDR3 comprises QNGHSFPLT. In another embodiment, there is provided a polypeptide that binds the same antigen as that of monoclonal antibody 8H9, wherein the polypeptide comprises NYDIN, WIFPGDGSTQY, QTTATWFAY, RASQSISDYLH, YASQSIS, and QNGHSFPLT.

Research Organization:
Sloan-Kettering Inst. for Cancer Research, New York, NY (United States)
Sponsoring Organization:
USDOE
DOE Contract Number:
FG02-93ER61658
Assignee:
Sloan-Kettering Institute for Cancer Research (New York, NY)
Patent Number(s):
9,062,110
Application Number:
13/858,234
OSTI ID:
1185299
Resource Relation:
Patent File Date: 2013 Apr 08
Country of Publication:
United States
Language:
English

References (87)

Detection of (11; 22)(q24;q12) Translocation-Bearing Cells in Peripheral Blood Progenitor Cells of Patients With Ewing's Sarcoma Family of Tumors journal March 1995
T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients journal February 1996
In vivo tracking of tumor-specific T cells journal April 2001
Uses of monoclonal antibody 8H9 patent August 2013
Surface Antigen Expression and Complement Susceptibility of Differentiated Neuroblastoma Clones journal March 2000
SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2 journal January 1994
Expression of 300-kilodalton intermediate filament-associated protein distinguishes human glioma cells from normal astrocytes. journal September 1993
Desmoplastic Small Round Cell Tumor: II: An Ultrastructural and Immunohistochemical Study with Emphasis on New Immunohistochemical Markers journal January 1998
Comparison of purity and enrichment of CD34 + cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems journal January 1995
Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy: Quantitative imaging of I-124 journal May 1991
Intra-abdominal desmoplastic small cell tumor: A light microscopic, immunocytochemical, ultrastructural, and flow cytometric study journal August 1993
Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma journal May 1993
New monoclonal antibodies specific for human sarcomas journal July 1986
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia journal June 1997
The Diagnostic Utility of Desmin: A Study of 584 Cases and Review of the Literature journal March 1990
Ewing Family Tumors: Potential Prognostic Value of Reverse-Transcriptase Polymerase Chain Reaction Detection of Minimal Residual Disease in Peripheral Blood Samples journal January 1998
Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas journal November 1993
Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients journal January 1995
Diagnostic imaging of human neuroblastoma with radiolabeled antibody. journal November 1986
A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2 journal May 1991
High-dose sequential chemotherapy and autologous stem cell reinfusion in advanced pediatric solid tumors journal December 1997
Immunocytokines: A Promising Approach to Cancer Immunotherapy journal December 1998
Functional expression of chimeric receptor genes in human T cells journal February 2001
Role of High-Dose Chemotherapy With Hematopoietic Stem Cell Rescue in the Treatment of Metastatic or Recurrent Rhabdomyosarcoma journal January 2001
Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen patent December 1993
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. journal March 1994
Phage Library-derived Human Anti-TETA and Anti-DOTA ScFv for Pretargeting RIT journal February 1999
Monoclonal antibody against ependymoma-derived cell line journal January 1992
Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays journal August 1989
Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics journal December 1999
A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a journal May 1992
Intergroup Rhabdomyosarcoma Study: Update for Pathologists journal November 1998
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease journal November 1979
Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross-organ beta doses journal January 1996
Characteristics of the cell surface antigen, p72, associated with a variety of human tumours and mitogen-stimulated T-lymphoblasts journal June 1984
Human Glioma-Specific Antigens Detected by Monoclonal Antibodies journal January 1992
Continuous cultures of fused cells secreting antibody of predefined specificity journal August 1975
Implementation of a Monte Carlo dosimetry method for patient-specific internal emitter therapy journal July 1997
Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immmunotherapy journal June 1997
Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry journal January 1993
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma journal November 1998
A Monte Carlo approach to patient-specific dosimetry journal September 1996
Humanized immunoglobulins patent December 1997
Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene journal August 1994
Pharmacokinetics and acute toxicology of intraventricular 131I-monoclonal antibody targeting disialoganglioside in non-human primates journal January 1997
Gene-marking to trace origin of relapse after autologous bone-marrow transplantation journal January 1993
Method for preparation of single chain antibodies patent April 2012
Biotechnological and gene therapeutic strategies in cancer treatment journal June 1995
Clinical Applications of CD34 + Peripheral Blood Progenitor Cells (PBPC) journal March 2000
131I Radioconjugated Antibodies for the Locoregional Radioimmunotherapy of High-grade Malignant Glioma: Phase I and II Study journal January 1999
Monoclonal antibody against human glioblastoma multiforme (U-87MG) immunoprecipitates a protein of molecular mass 38 kDa and inhibits tumor growth in nude mice journal January 1995
Immunogenic peptides of prostate specific antigen patent December 2001
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. journal January 1993
Antigen-dependent CD28 Signaling Selectively Enhances Survival and Proliferation in Genetically Modified Activated Human Primary T Lymphocytes journal August 1998
Impact of chimeric immune receptor extracellular protein domains on T cell function journal March 1999
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations journal April 1997
CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilisation in multiple myeloma journal June 2000
Autologous stem cell transplantation for high-risk pediatric solid tumors journal September 1999
Efficient Discrimination between Different Densities of Target Antigen by Tetracycline-Regulatable T Bodies journal March 1999
Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells journal March 1995
Yttrium-90 biodistribution by yttrium-87 imaging: A theoretical feasibility analysis journal August 1998
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR journal November 1999
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary report journal January 1995
Uses of monoclonal antibody 8H9 patent April 2013
Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial journal February 1996
Radionuclide photon dose kernels for internal emitter dosimetry journal May 1996
Multi-stage cascade boosting vaccine patent October 2000
Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy book January 1994
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. journal April 1988
Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues journal September 2000
Title>Additive cytotoxicity of different monoclonal antibody-cobra venom factor conjugates for human neuroblastoma cells journal November 1997
Detection of Prostatic Specific Membrane Antigen Messenger RNA Using Immunobead Reverse Transcriptase Polymerase Chain Reaction journal January 1999
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma journal January 1995
Hexabrachion Protein (Tenascin, Cytotactin, Brachionectin) in Connective Tissues, Embryonic Brain, and Tumors journal January 1988
The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour journal November 1997
The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y journal June 1991
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain journal July 1993
Multimodality Diagnostics and Megatherapy in Poor Prognosis Ewing's Tumor Patients journal October 1999
Common Musculoskeletal Tumors of Childhood and Adolescence journal July 1999
Low incidence of molecular evidence for tumour in PBPC harvests from patients with high risk Ewing tumours journal August 1999
Radiotherapy and High-Dose Chemotherapy in Advanced Ewing's Tumors journal October 1999
Radioimmunotherapy with alpha-emitting nuclides journal September 1998
Disialoganglioside GD2 anti-idiotypic monoclonal antibodies journal May 1993
Expression of CD44 splice variants in human primary brain tumors journal December 1995
Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR: Monitoring of MRD by Real-time Quantitation journal August 1998
Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor journal July 1990
Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same patent October 2003

Similar Records

Uses of monoclonal antibody 8H9
Patent · Tue Apr 10 00:00:00 EDT 2018 · OSTI ID:1185299

Uses of monoclonal antibody 8H9
Patent · Tue Aug 06 00:00:00 EDT 2013 · OSTI ID:1185299

Uses of monoclonal antibody 8H9
Patent · Tue Jun 15 00:00:00 EDT 2010 · OSTI ID:1185299